🇺🇸 Antiplatelets in United States

10 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 10

Most-reported reactions

1. Angina Pectoris — 1 report (10%)
2. Arthritis Bacterial — 1 report (10%)
3. Basal Ganglia Haemorrhage — 1 report (10%)
4. Blood Creatine Phosphokinase Increased — 1 report (10%)
5. Coagulopathy — 1 report (10%)
6. Dizziness — 1 report (10%)
7. Drug Ineffective — 1 report (10%)
8. Drug Interaction — 1 report (10%)
9. Generalised Tonic-Clonic Seizure — 1 report (10%)
10. Haemoglobin Urine Present — 1 report (10%)

Source database →

Frequently asked questions

Is Antiplatelets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Antiplatelets in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.